News
Press Releases & Media
Latest updates from Carvolix and our portfolio companies.
Le JDD – Philippe Pouletty, CEO of Truffle Capital “The government must back science and innovation”
Press review
Le JDD – Philippe Pouletty, CEO of Truffle Capital “The government must back science and innovation”
January 18, 2026
BioWorld – Affluent becoming Carvolix after acquisitions
Press review
BioWorld – Affluent becoming Carvolix after acquisitions
January 14, 2026
CFNEWS – Three Truffle Capital companies join forces
Press review
CFNEWS – Three Truffle Capital companies join forces
January 5, 2026
L’express – Abivax: From Havana to Nasdaq
Press review
L’express – Abivax: From Havana to Nasdaq
December 18, 2025
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
Press Release
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
December 2025
Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
Press Release
Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
December 2025